Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Clinical Observation of Sequential Prophylaxis with Letermovir Injection and Tablets for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Aiming Pang, Yawei Zheng, Shulian Chen, Yuyan Shen, Xiaoli Zhao, Xiaofei Ni, Lining Zhang, Jiali Wang, Wenbin Cao, Xin Chen, Yigeng Cao, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7292.

https://doi.org/10.1182/blood-2024-207795

Published: 2024

Journal Articles

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Dewan Zhao, Wenbin Cao, Gang Li, Ying Zhang, Xiaohui Zheng, Xin Chen, Weihua Zhai, Qiaoling MA, Rongli Zhang, Jialin Wei, Aiming Pang, Yi He, Donglin Yang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7432.

https://doi.org/10.1182/blood-2024-205145

Published: 2024

Journal Articles

Clinical Characteristics and Treatment Response of Chronic Disseminated Candidiasis in Patients with Hematological Disorders

Zhangjie Chen, Sizhou Feng, Xin Chen, Erlie Jiang

Blood (2024) 144 (Supplement 1): 7683.

https://doi.org/10.1182/blood-2024-194289

Published: 2024

Journal Articles

The Comparison between Chimeric Mouse-Human and Humanized Anti-CD25 Monoclonal Antibody for Steroid-Refractory Acute Graft-Versus-Host Disease

Xinhui Zheng, Xin Chen, Yawei Zheng, Weihua Zhai, Donglin Yang, Jialin Wei, Aiming Pang, Mingzhe Han, Erlie Jiang

Blood (2024) 144 (Supplement 1): 2144.

https://doi.org/10.1182/blood-2024-207001

Published: 2024

Journal Articles

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

Mengnan Lv, Yi He, Donglin Yang, Qiaoling MA, Aiming Pang, Weihua Zhai, Jialin Wei, Xin Chen, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5900.

https://doi.org/10.1182/blood-2023-188534

Published: 2023

Journal Articles

Circulating Exosomal miRNA Signature As a Potential Risk Factor for DNA Virus Infection in Patients with Multiple Myeloma

Xin Chen, Liwen Wang, Zuqun Deng, Yishu Tang, Qian Cheng, Depei Wu, Xin Li

Blood (2023) 142 (Supplement 1): 1926.

https://doi.org/10.1182/blood-2023-185287

Published: 2023

Journal Articles

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

Xiaoyu Zhang, Donglin Yang, Aiming Pang, Yi He, Jialin Wei, Rongli Zhang, Weihua Zhai, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7027.

https://doi.org/10.1182/blood-2023-182816

Published: 2023

Journal Articles

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Xiaofei Ni, Weihua Zhai, AiMing Pang, Donglin Yang, Xin Chen, Qiaoling MA, Jialin Wei, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 6974.

https://doi.org/10.1182/blood-2023-181449

Published: 2023

Journal Articles

Diagnostic Performance and Clinical Impacts of Metagenomic Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

Chunhui Xu, Xin Chen, Huiming Yi, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5020.

https://doi.org/10.1182/blood-2023-187950

Published: 2023

Journal Articles

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Xiaoyu Zhang, Yanhong Zhao, Rongli Zhang, Weihua Zhai, Yi He, Jialin Wei, Donglin Yang, Aiming Pang, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5892.

https://doi.org/10.1182/blood-2023-184400

Published: 2023

Journal Articles

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Yanhong Zhao, Weihua Zhai, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5893.

https://doi.org/10.1182/blood-2023-184565

Published: 2023

Journal Articles

Explorations of Post-DLI Low-Dose Cyclophosphamide for Preventing Severe aGVHD

Xinhui Zheng, Xin Chen, Erlie Jiang

Blood (2023) 142 (Supplement 1): 2195.

https://doi.org/10.1182/blood-2023-179634

Published: 2023

Journal Articles

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis

Blood (2023) 141 (9): 1070–1086.

https://doi.org/10.1182/blood.2022017262

Published: 2023

Includes: Supplemental data

Journal Articles

Comparison of Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy for Patients with Severe Hepatitis-Associated Aplastic Anemia

Xiaoyu Zhang, Wenrui Yang, Jialin Wei, Rongli Zhang, Guixin Zhang, Xin Chen, Yong Huang, Yingchang Mi, Sizhou Feng, Mingzhe Han, Li Zhang, Yi He, Erlie Jiang

Blood (2022) 140 (Supplement 1): 12941–12942.

https://doi.org/10.1182/blood-2022-165138

Published: 2022

Journal Articles

Combination of Cytogenetic Classification and MRD Status Correlates with Outcomes of Autologous Versus Allogeneic Stem Cell Transplantation in Adults with B Cell-Acute Lymphoblastic Leukemia in First Remission

Rongli Zhang, Mengnan Lyu, Yi He, Donglin Yang, Aiming Pang, Jialin Wei, Qiaoling Ma, Weihua Zhai, Xin Chen, Guixin Zhang, Sizhou Feng, Mingzhe Han, Erlie Jiang

Blood (2022) 140 (Supplement 1): 7714–7715.

https://doi.org/10.1182/blood-2022-165085

Published: 2022

Journal Articles

Potent and Orally Bioavailable BCL6 PROTAC TM Degraders Demonstrate Efficacy in Pre-Clinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

Blood (2021) 138 (Supplement 1): 2272.

https://doi.org/10.1182/blood-2021-149654

Published: 2021

Journal Articles

The Colony-Stimulating Factor 3 Receptor M696T Mutated in a Patient with Ph+ Acute Lymphoblastic Leukemia

Xin Chen, Bichen Wang, Aiming Pang, MD PhD, Erlie Jiang, Yajing Chu, PhD, Weiping Yuan, PhDMD, Sizhou Feng, Ming-Zhe Han, MD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-133772

Published: 2020

Journal Articles

BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL

Jing Lu, PhD, Yimin Qian, PhD, Kanak Raina, PhD, Martha Altieri, MS, Hanqing Dong, PhD, Jing Wang, PhD, Xin Chen, PhD, Andrew Crew, PhD, Kevin Coleman, PhD, Craig Crews, PhD, James Winkler, PhD

Blood (2015) 126 (23): 2050.

https://doi.org/10.1182/blood.V126.23.2050.2050

Published: 2015

Journal Articles

Mechanism Research of Magnetic Nanoparticle Fe 3 O 4 and 5-Bromotetrandrine On Reversal of Multidrug Resistance in K562/A02 Leukemic Cells.

Bao-An Chen, Wei-Wei Wu, Jian Cheng, Feng Gao, Wen-Lin Xu, Chong Gao, Jia-Hua Ding, Xin-Chen Sun, Cui-Rong Xu, Ning-Na Chen, Guo-Hua Xia, Xue-Mei Wang, Wen-Ji Chen, Li-Jie Liu, Xiao-Mao Li

Blood (2009) 114 (22): 4827.

https://doi.org/10.1182/blood.V114.22.4827.4827

Published: 2009

Journal Articles

Reversal of Multidrug Resistance by Magnetic Fe3O4 Nanoparticle Copolymerizating Daunorubicin and mdr1-shRNA Expression Vetor in Leukemia Cells.

Bao-An Chen, Peipei Mao, Jian Cheng, Feng Gao, Jia-Hua Ding, Chong Gao, Wei Zhang, Cui-Rong Xu, Wen-Lin Xu, Xin-Chen Sun, Ning-Na Chen, Xiao-Mao Li, Xue-Mei Wang

Blood (2009) 114 (22): 4829.

https://doi.org/10.1182/blood.V114.22.4829.4829

Published: 2009

NARROW

Clinical Observation of Sequential Prophylaxis with Letermovir Injection and Tablets for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Peripheral Blood Stem Cell Transplantation for Myeloid Sarcoma: A Single-Center Experience

Clinical Characteristics and Treatment Response of Chronic Disseminated Candidiasis in Patients with Hematological Disorders

The Comparison between Chimeric Mouse-Human and Humanized Anti-CD25 Monoclonal Antibody for Steroid-Refractory Acute Graft-Versus-Host Disease

Inotuzumab Ozogamicin in Lymphoid B Cell Malignancy：a Single Center Analysis in the Real World

Circulating Exosomal miRNA Signature As a Potential Risk Factor for DNA Virus Infection in Patients with Multiple Myeloma

A Real-World Efficacy of Letermovir Primary Prophylaxis for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation in China: A Single-Center Retrospective Analysis

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Diagnostic Performance and Clinical Impacts of Metagenomic Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Explorations of Post-DLI Low-Dose Cyclophosphamide for Preventing Severe aGVHD

A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis

Comparison of Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy for Patients with Severe Hepatitis-Associated Aplastic Anemia

Combination of Cytogenetic Classification and MRD Status Correlates with Outcomes of Autologous Versus Allogeneic Stem Cell Transplantation in Adults with B Cell-Acute Lymphoblastic Leukemia in First Remission

Potent and Orally Bioavailable BCL6 PROTAC TM Degraders Demonstrate Efficacy in Pre-Clinical Models of Diffuse Large B-Cell Lymphoma (DLBCL)

The Colony-Stimulating Factor 3 Receptor M696T Mutated in a Patient with Ph+ Acute Lymphoblastic Leukemia

BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL

Mechanism Research of Magnetic Nanoparticle Fe 3 O 4 and 5-Bromotetrandrine On Reversal of Multidrug Resistance in K562/A02 Leukemic Cells.

Reversal of Multidrug Resistance by Magnetic Fe3O4 Nanoparticle Copolymerizating Daunorubicin and mdr1-shRNA Expression Vetor in Leukemia Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only